Start of Coverage: 25-11-2015
We have cut our FY 2024-26 EPS by c.5% and our PT from EUR19 to EUR18 to reflect negative LfL and negative operating leverage throughout H2 as the group commits to further reinvesting in prices to drive volume growth on toughening comps.
Analyst: Clément Genelot
e-mail: cgenelot@bryangarnier.com
| Analyst | Price target | Recommendation | Date |
| Clément Genelot | 18.00 € | Neutral | 9 Oct 2024 |
| Clément Genelot | 19.00 € | Neutral | 4 Apr 2024 |
| Clément Genelot | 20.00 € | Neutral | 8 Mar 2024 |
| Clément Genelot | 21.00 € | Neutral | 25 Jan 2024 |
| Clément Genelot | 25.00 € | Buy | 2 Oct 2023 |
| - | Under Revision | Under Revision | 17 Jul 2018 |
| Antoine Parison | 16.00 € | Buy | 26 Apr 2018 |
| Antoine Parison | 15.00 € | Neutral | 13 Jan 2017 |
| Antoine Parison | 13.50 € | Neutral | 25 Nov 2015 |
The information presented refers to recommendations issued by analysts that follow the Jerónimo Martins share. For more information, please read the Analysts Coverage section in this website’s Terms and Conditions.